Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2009-07-13
2011-11-15
Minnifield, Nita M (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387500, C530S388600, C514S001100, C424S178100
Reexamination Certificate
active
08058401
ABSTRACT:
The present invention relates generally to a method of eliciting or otherwise inducing an effective immune response to a micro-organism and compositions for use therein. More particularly, the present invention relates to a method of inducing an immune response to a parasite utilising an immunogenic composition comprising a glycosylphosphatidylinositol (referred to herein as “GPI”) inositolglycan domain or its derivatives. Even more particularly, the present invention contemplates an immunogenic composition comprising thePlasmodium falciparumGPI inositolglycan domain or its derivatives. The present invention is useful, inter alia, as a prophylactic and/or therapeutic treatment for disease conditions such as, for example, infection by parasites and in particular infection byPlasmodiumspecies.
REFERENCES:
patent: 5726166 (1998-03-01), Playfair et al.
patent: 5968742 (1999-10-01), Bandman et al.
patent: 6113917 (2000-09-01), Fasel et al.
patent: 6551586 (2003-04-01), Davidson et al.
patent: 7575755 (2009-08-01), Schofield
patent: 7928077 (2011-04-01), Wong et al.
patent: 7932361 (2011-04-01), Ruben et al.
patent: 7968689 (2011-06-01), Rosen et al.
patent: 2005/0169935 (2005-08-01), Aylsworth et al.
patent: 2006/0089330 (2006-04-01), Seeberger et al.
patent: 2006/0147476 (2006-07-01), Schofield
patent: 2008/0044428 (2008-02-01), Schofield
patent: 2009/0275737 (2009-11-01), Schofield
patent: 65674/94 (1994-12-01), None
patent: 4311580 (1994-08-01), None
patent: 1113815 (2001-07-01), None
patent: 1545599 (2005-06-01), None
patent: WO 97/10249 (1997-03-01), None
patent: WO 00/24406 (2000-05-01), None
patent: WO 00/24406 (2000-05-01), None
patent: WO 2004/0011026 (2004-02-01), None
patent: WO 2005/120519 (2005-12-01), None
Riley et al, Parasite Immunology, 2006, 28:35-49.
Greenspan et al, Nature Biotechnology 17:936-937, 1999.
Harlow et al In Antibodies A Laboratory Manual, Cold Spring Harbor Press, 1988, Chapter 3, pp. 23-35.
Greenbaum et al, Journal of Molecular Recognition, 20(2):75-82, 2007.
Herbert, Dictionary of Immunology 4th Ed, Academic Press, 1995 pp. 58-59.
Gerold et al., “Structual analysis of the glycosyl-phosphatidylinositol membrane anchor of the merozoite surface proteins-1 and -2 ofPlasmodium falciparum,” Molecular and Biochemical Parasitology(1996), vol. 75, pp. 131-143, Elsevier Science B.V.
Schofield et al., “Neutralizing monoclonal antiboides to glycosylphosphatidylinositol, the dominant TNF-a-inducing toxin ofPlasmodium falciparum: prospects for the immunotherapy of severe malaria,”Annals of Tropical Medicine and Parasitology(1993), vol. 87, No. 6, pp. 617-626, Liverpool School of Tropical Medicine.
Richardson et al., “Native and baculovirus-expressed forms of the immuno-protective protein BM86 fromBoophilus microplusare anchored to the cell membrane by a glycosyl-phosphatidyl inositol linkage,”Insect Molecular Biology(1993), vol. 1, No. 3, pp. 139-147.
Schofield et al., “Regulation of host cell function by glycosylphosphatidylinositols of the parasitic protozoa,”Immunology and Cell Biology(1996), vol. 74, pp. 555-563.
Scholfield et al., “Signal Transduction in Host Cells by a Glycosylphosphatidylinositol Toxin of Malaria Parasites,”J. Exp. Med.(Jan. 1993), vol. 177, pp. 145-153, The Rockefeller University Press.
Tachado et al., “Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: Activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties,”Proc. Natl. Acad. Sci.(Apr. 1997), vol. 94, pp. 4022-4027, The National Academy of Sciences of the USA.
Reymond et al., “Anchoring of an ImmunogenicPlasmodium falciparumCircumsporozoite Protein on the Surface ofDictyostelium discoideum,” The Journal of Biological Chemistry(1995), vol. 270, No. 21, pp. 12941-12947.
Schofield et al., “Signal transduction in host cells mediated by glycosylphosphatidylinositols of the parasitic protozoa, or why do the parasitic protozoa have so many GPI molecules?,”Brazilian J. Med. Biol. Res.(1994), vol. 27, pp. 249-254.
McConville et al., “The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes,”Biochem. J.(1993), vol. 294, pp. 305-324, Great Britain.
Elhay et al., “Lipophosphoglycan expression and virulence in Ricin-resistant variants ofLeishmania major,” Molecular and Biochemical Parasitology(1990), vol. 40, pp. 255-268, Elsevier Scinece Publishers B.V. (Biomedical Division).
Misek et al., “An Inositol Phosphate Glycan Derived from aTrypanosome bruceiGlycosyl-Phosphatidylinositol Mimics some of the Metabolic Actions of Insulin,”The Journal of Biological Chemistry(Aug. 15, 1992), vol. 267, No, 23, pp. 16266-16273, The American Society for Biochemistry and Molecular Biology, Inc.
Romero G. et al., “Anti-inositolglycan antibodies selectively block some of the actions of insulin in intact BC3H1 cells,”Proc. Natl. Acas. Sci. USA 87:1476-1480 (1990).
Schenkman S. et al., “Glycophosphatidylinositol-anchored proteins inmetacyclic trypomastigotes ofTrypanosoma cruzi”, Molecular and Biochemical Parasitology 29:141-152 (1988).
Galili U., “Evolution and pathophysiology of the human natural anti-α-galactosyl IgG (anti-Gal) antibody”,Sprigner Semin Immunopathol15:155-171 (1993).
Dumitriu, S., “Polysaccharides in Medicinal Applications”, Marcel Dekker, Inc. pp. 277-291 (1996).
Gowda et al., Parasitology Today, 1999, 15/4: 147-152.
Ramasamy, BBA, 1998, 1406: 10-27.
Clark at al., Parasitology Today, 2000, 16/10: 451-454.
Gowda, Microbes and Infection, 2002, 4:983-990.
Robert et al., Current Opinion in Microbiology, 2000, 3:395-403.
Butikofer et al., FASEBJ, 2001, 15:545-548.
Schofield et al., J. Immunology 156: 1886-1896, 1996.
Tachado at al., PNAS, USA, 94: 4022-4027, 1997.
Richardson et al., Insect Molecular Biology, vol. 1(issue 3): 139-147, 1993.
Tachado et al., J. Immunology 156: 1897-1907, 1996.
Fujita et al., BBA, Mar. 2008, 1780/3:410-420, Abstract only.
Debierre-Grockiego et al., Infection and Immunity, Oct. 2006, 74/10:5487-5496.
Streipen et al., J. Mol. Biol., 1997, 266: 797-813.
Paulick et al., J. Am. Chem. Soc., 2007, 129: 11543-11550.
Sauma et al., Molecular and Biochemical Parasitology 38: 199-210, 1990.
Tiede et al., Biol. Chem. 380: 503-523, 1999.
Gazzinelli et al., Ciencia e Cultura 51(5/6): 411-428, 1999.
Kedees et al., European J. Cell Biology 79: 52-61, 2000.
Schofield et al., Science, 283: 225-229, 1999.
Tachado et al., Parasite Immunology 21: 609-617, 1999.
Garg et al., JBC, 272/19: 12482-12491, 1997.
Zunecker et al., Indian J. biochemistry and Biophysics, 34: 105-109, 1997.
Tachado et al., BRRC 205/2: 984-991, 1994.
Eckert et al., European J. Cell Biol. 69/Suppl 42: 148, Abstract #443, 1996.
Moran et al., JCB, 125/2: 333-343, 1994.
Schofield et at, Nature 418: 785-789, 2002.
Campos et al., J. Immunology, 167: 416-423, 2001.
Delorenzi et al., Infection and Immunity 70/8: 4510-4522, 2002.
Schofield, In: Parotysmal Nocturnal Hemoglobineria and the Glycosylphosphatidylinasitol-linked proteins, Editor Young et al., pp. 179-198, 2000.
Azzouz et al., Glycobiology, 10/2: 177-183, 2000.
Fanning et al., Vaccine, 2003, 21:3228-3235.
Clark et al., Pharmacology and Therapetuics, 2003, 99: 221-260.
Dekker, et al., Molecular and Biochemical Parasitology, 2004, 137: 143-149.
Lu et al., Tetrahedron Letters, 2004, 45: 879-882.
Bruna Romero et al., Vaccine, 2004, 22: 3575-3584.
Glaser, Current Opinion in Structural Biology, 1993, ¾: 475-481, Abstract only.
Minnifield Nita M
Scully , Scott, Murphy & Presser, P.C.
The Walter and Eliza Hall Institute of Medical Research
LandOfFree
Immunogenic compositions and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic compositions and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic compositions and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4287399